Match tier
Listed
Presence
Current · Arkansas
Last published
2024
Sources
OpenAlex · ORCID
Refreshed
2026-10-07
L
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Lauren Russell's research focuses on the pharmacological effects and potential toxicity of synthetic cathinones and cannabinoids, specifically investigating their interactions with cannabinoid receptors. Her work includes analyzing the pharmacodynamic properties of synthetic cannabinoid metabolites, such as 5F-MDMB-PINACA, at CB1 receptors. Russell also studies factors influencing health and behavior in specific populations, including cannabis use in individuals over 65 and adapting social risk screening programs for veterans. Her research extends to animal models, examining the impact of laboratory housing conditions on core temperature and locomotor activity in mice. Russell has published 23 works, with an h-index of 5 and 88 citations, and collaborates with researchers at the University of Arkansas for Medical Sciences, including Alison Oliveto and William E. Fantegrossi.
Metrics
- h-index: 5
- Publications: 21
- Citations: 94
Selected Publications
-
Factors Related to Cannabis Use in Individuals Over 65 (2024)
-
484 A Preliminary Study on the Pharmacodynamics of Oral Cannabis Ingestion in Older Adults (2024)
-
289 Heart Rate Variability in Opioid Use Disordered Participants Undergoing Buprenorphine-Assisted Detoxification (2023)
-
Metabolites of Synthetic Cannabinoid 5F-MDMB-PINACA Retain Affinity, Act as High Efficacy Agonists and Exhibit Atypical Pharmacodynamic Properties at CB1 Receptors (2022)
-
Effects of Ambient Temperature and Social Housing on Locomotor Activity, Thermoregulation, and Weight Loss Following “Binge” Administration of Structurally‐Related Abused Psychostimulants (2020)
-
Effects of ambient temperature on place conditioning elicited by abused psychostimulants in mice: role of methylexenedioxy moiety (2020)
-
The synthetic cathinone 3,4-methylenedioxypyrovalerone increases impulsive action in rats (2020)
-
Acute Administration of 3,4‐Methylenedioxypyrovalerone (MDPV) Increases Motor Impulsivity in Rats (2019)
-
Locomotor Effects of Substituted Amphetamines and Cathinones in Mice: Structure‐Activity Relationships (2019)
-
Repeated administration of synthetic cathinone 3,4-methylenedioxypyrovalerone persistently increases impulsive choice in rats (2019)
-
Clinical Characteristics of Arkansas Residents Who Have Medical Needs for Cannabis (2019)
-
In Utero Exposure to Norbuprenorphine, a Major Metabolite of Buprenorphine, Induces Fetal Opioid Dependence and Leads to Neonatal Opioid Withdrawal Syndrome (2019)
-
Predicting Impulsivity and Compulsivity in Mice Using a Rapid Drug Abuse Liability Battery (RDALB) Assessing Hyperneophagia, Locomotor Reactivity, and Novelty Preference (2018)
-
Effects of Environmental Variables on the Pharmacological Actions of “Bath Salts” Constituent 3,4‐Methylenedioxypyrovalerone (MDPV) in Mice (2018)
-
2421 Development and validation of a translational rat model of neonatal abstinence syndrome (2018)
Collaboration Network
Top Collaborators
William E. Fantegrossi
University of Arkansas for Medical Sciences
14 shared publications
In database
- In Utero Exposure to Norbuprenorphine, a Major Metabolite of Buprenorphine, Induces Fetal Opioid Dependence and Leads to Neonatal Opioid Withdrawal Syndrome
- Effects of orally self-administered bath salt constituent 3,4-methylenedioxypyrovalerone (MDPV) in mice
- Metabolites of Synthetic Cannabinoid 5F-MDMB-PINACA Retain Affinity, Act as High Efficacy Agonists and Exhibit Atypical Pharmacodynamic Properties at CB1 Receptors
- Repeated administration of synthetic cathinone 3,4-methylenedioxypyrovalerone persistently increases impulsive choice in rats
- The synthetic cathinone 3,4-methylenedioxypyrovalerone increases impulsive action in rats
Showing 5 of 14 shared publications
William S. Hyatt
University of Arkansas for Medical Sciences (US)
8 shared publications
- Repeated administration of synthetic cathinone 3,4-methylenedioxypyrovalerone persistently increases impulsive choice in rats
- The synthetic cathinone 3,4-methylenedioxypyrovalerone increases impulsive action in rats
- Effects of Ambient Temperature and Social Housing on Locomotor Activity, Thermoregulation, and Weight Loss Following “Binge” Administration of Structurally‐Related Abused Psychostimulants
- Locomotor Effects of Substituted Amphetamines and Cathinones in Mice: Structure‐Activity Relationships
- Effects of Environmental Variables on the Pharmacological Actions of “Bath Salts” Constituent 3,4‐Methylenedioxypyrovalerone (MDPV) in Mice
Showing 5 of 8 shared publications
Michael D. Berquist
University of Arkansas for Medical Sciences
6 shared publications
In database
- Repeated administration of synthetic cathinone 3,4-methylenedioxypyrovalerone persistently increases impulsive choice in rats
- Locomotor Effects of Substituted Amphetamines and Cathinones in Mice: Structure‐Activity Relationships
- Effects of Environmental Variables on the Pharmacological Actions of “Bath Salts” Constituent 3,4‐Methylenedioxypyrovalerone (MDPV) in Mice
- Predicting Impulsivity and Compulsivity in Mice Using a Rapid Drug Abuse Liability Battery (RDALB) Assessing Hyperneophagia, Locomotor Reactivity, and Novelty Preference
- Acute Administration of 3,4‐Methylenedioxypyrovalerone (MDPV) Increases Motor Impulsivity in Rats
Showing 5 of 6 shared publications
Kenner C. Rice
National Institute on Drug Abuse (US)
3 shared publications
- Effects of orally self-administered bath salt constituent 3,4-methylenedioxypyrovalerone (MDPV) in mice
- Repeated administration of synthetic cathinone 3,4-methylenedioxypyrovalerone persistently increases impulsive choice in rats
- The synthetic cathinone 3,4-methylenedioxypyrovalerone increases impulsive action in rats
Christian V. Cabanlong
University of Arkansas for Medical Sciences (US)
3 shared publications
- In Utero Exposure to Norbuprenorphine, a Major Metabolite of Buprenorphine, Induces Fetal Opioid Dependence and Leads to Neonatal Opioid Withdrawal Syndrome
- Metabolites of Synthetic Cannabinoid 5F-MDMB-PINACA Retain Affinity, Act as High Efficacy Agonists and Exhibit Atypical Pharmacodynamic Properties at CB1 Receptors
- 2421 Development and validation of a translational rat model of neonatal abstinence syndrome
Kyle R. Urquhart
University of Arkansas for Medical Sciences
3 shared publications
In database
- In Utero Exposure to Norbuprenorphine, a Major Metabolite of Buprenorphine, Induces Fetal Opioid Dependence and Leads to Neonatal Opioid Withdrawal Syndrome
- 2421 Development and validation of a translational rat model of neonatal abstinence syndrome
- Effects of Ambient Temperature and Social Housing on Locomotor Activity, Thermoregulation, and Weight Loss Following “Binge” Administration of Structurally‐Related Abused Psychostimulants
Kevin Sean Murnane
Mercer University (US)
3 shared publications
- Repeated administration of synthetic cathinone 3,4-methylenedioxypyrovalerone persistently increases impulsive choice in rats
- The synthetic cathinone 3,4-methylenedioxypyrovalerone increases impulsive action in rats
- Effects of Environmental Variables on the Pharmacological Actions of “Bath Salts” Constituent 3,4‐Methylenedioxypyrovalerone (MDPV) in Mice
Alison H. Oliveto
University of Arkansas for Medical Sciences
3 shared publications
In database
- 289 Heart Rate Variability in Opioid Use Disordered Participants Undergoing Buprenorphine-Assisted Detoxification
- 484 A Preliminary Study on the Pharmacodynamics of Oral Cannabis Ingestion in Older Adults
- Factors Related to Cannabis Use in Individuals Over 65
Lisa K. Brents
University of Arkansas at Fayetteville
2 shared publications
In database
- In Utero Exposure to Norbuprenorphine, a Major Metabolite of Buprenorphine, Induces Fetal Opioid Dependence and Leads to Neonatal Opioid Withdrawal Syndrome
- 2421 Development and validation of a translational rat model of neonatal abstinence syndrome
Bryce A. Griffin
University of Arkansas at Fayetteville
2 shared publications
In database
- In Utero Exposure to Norbuprenorphine, a Major Metabolite of Buprenorphine, Induces Fetal Opioid Dependence and Leads to Neonatal Opioid Withdrawal Syndrome
- 2421 Development and validation of a translational rat model of neonatal abstinence syndrome
Caitlin O. Caperton
University of Arkansas at Fayetteville
2 shared publications
In database
- In Utero Exposure to Norbuprenorphine, a Major Metabolite of Buprenorphine, Induces Fetal Opioid Dependence and Leads to Neonatal Opioid Withdrawal Syndrome
- 2421 Development and validation of a translational rat model of neonatal abstinence syndrome
Catheryn D. Wilson
University of Arkansas at Fayetteville
2 shared publications
In database
- In Utero Exposure to Norbuprenorphine, a Major Metabolite of Buprenorphine, Induces Fetal Opioid Dependence and Leads to Neonatal Opioid Withdrawal Syndrome
- 2421 Development and validation of a translational rat model of neonatal abstinence syndrome
Amy L. Patton
University of Arkansas at Fayetteville (US)
2 shared publications
- In Utero Exposure to Norbuprenorphine, a Major Metabolite of Buprenorphine, Induces Fetal Opioid Dependence and Leads to Neonatal Opioid Withdrawal Syndrome
- 2421 Development and validation of a translational rat model of neonatal abstinence syndrome
Alexander W. Alund
University of Arkansas at Fayetteville
2 shared publications
In database
- In Utero Exposure to Norbuprenorphine, a Major Metabolite of Buprenorphine, Induces Fetal Opioid Dependence and Leads to Neonatal Opioid Withdrawal Syndrome
- 2421 Development and validation of a translational rat model of neonatal abstinence syndrome
Samuel Michael Owens
University of Arkansas at Fayetteville
2 shared publications
In database
- In Utero Exposure to Norbuprenorphine, a Major Metabolite of Buprenorphine, Induces Fetal Opioid Dependence and Leads to Neonatal Opioid Withdrawal Syndrome
- 2421 Development and validation of a translational rat model of neonatal abstinence syndrome
Similar Researchers
Based on overlapping research topics
Jeffery H. Moran
University of Arkansas for Medical Sciences
Cannabis and Cannabinoid Research
Pharmacological Effects and Toxicity Studies
Receptor Mechanisms and Signaling
Justin R. Nickell
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Receptor Mechanisms and Signaling
Animal Behavior and Welfare Studies
J S James
University of Arkansas for Medical Sciences
Cannabis and Cannabinoid Research
Pharmacological Effects and Toxicity Studies
Receptor Mechanisms and Signaling
Catheryn D. Wilson
University of Arkansas for Medical Sciences
Cannabis and Cannabinoid Research
Pharmacological Effects and Toxicity Studies
Animal Behavior and Welfare Studies
Lirit N. Franks
University of Arkansas for Medical Sciences
Cannabis and Cannabinoid Research
Pharmacological Effects and Toxicity Studies
Receptor Mechanisms and Signaling
William E. Fantegrossi
University of Arkansas for Medical Sciences
Cannabis and Cannabinoid Research
Pharmacological Effects and Toxicity Studies
Receptor Mechanisms and Signaling